Page 2 - Cone Cells News Today

So we and others, over the last five to ten years, have developed a new viral vector, and were manufacturing that here to deliver the genes were delivering into the body. in addition, at meira, weve actually developed over the last seven years a totally new technology which allows us to, in the future, control how those genes that are delivered to the body are activated using pills. one of the six clinical trials taking place here is targeting an inherited eye condition called retinitis pigmento...

Here to deliver the genes were delivering into the body. in addition, at meira, weve actually developed over the last seven years a totally new technology which allows us to, in the future, control how those genes that are delivered to the body are activated using pills. one of the six clinical trials taking place here is targeting an inherited eye condition called retinitis pigmentosa. it causes light—detecting cells in the retina to break down over time, causing a person to eventually lose v...